Giant Cell Arteritis

If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu.

Study Name

Medication Involved

Disease Studied

Currently Enrolling

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) YES GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
VCRC Genetic Repository One-Time DNA Study NO GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
Researching Micro-Organisms in Large-Vessel Vasculitis (RESOLVE) NO GCA & Takayasu's arteritis NO
Vessel Wall Enhancement in Giant Cell Arteritis (VEGA) NO GCA YES
Tissue Repository Collection Protocol NO GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis YES
SELECT-GCA: Upadacitinib in Giant Cell Arteritis YES GCA NO

A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)

YES GCA YES